INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Feb 07, 2024 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 3,127 | $950.43 | 54,334 |
Feb 07, 2024 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 1,237 | $951.49 | 53,097 |
Feb 07, 2024 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 1,059 | $952.49 | 52,038 |
Feb 07, 2024 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 19 | $953.00 | 52,019 |
Feb 06, 2024 |
EVP Finance CFO
Trans History: 465
|
EVP Finance CFO | Form 4 | Other acquisition or disposition | -- | -- | 270 |
Feb 06, 2024 |
EVP Commercial
Trans History: 139
|
EVP Commercial | Form 4 | Other acquisition or disposition | -- | -- | 158 |
Feb 06, 2024 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 5,834 |
Feb 06, 2024 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 4,605 |
Feb 05, 2024 |
EVP Commercial
Trans History: 139
|
EVP Commercial | Form 4 | Open market or private sale of non-derivative or derivative security | 1,000 | $934.71 | 13,789 |
Feb 02, 2024 |
EVP Finance CFO
Trans History: 465
|
EVP Finance CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 400 | $378.98 | 23,974 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.